Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 36% ± 18% | |
endothelial cell | 16 studies | 29% ± 12% | |
glutamatergic neuron | 13 studies | 49% ± 26% | |
oligodendrocyte | 13 studies | 35% ± 14% | |
microglial cell | 13 studies | 35% ± 12% | |
pericyte | 13 studies | 19% ± 4% | |
ciliated cell | 13 studies | 31% ± 13% | |
fibroblast | 12 studies | 26% ± 11% | |
GABAergic neuron | 11 studies | 50% ± 28% | |
epithelial cell | 11 studies | 35% ± 17% | |
oligodendrocyte precursor cell | 11 studies | 36% ± 15% | |
macrophage | 10 studies | 28% ± 9% | |
epithelial cell of proximal tubule | 9 studies | 37% ± 13% | |
smooth muscle cell | 9 studies | 24% ± 6% | |
adipocyte | 9 studies | 33% ± 11% | |
endothelial cell of lymphatic vessel | 8 studies | 20% ± 5% | |
neuron | 7 studies | 41% ± 17% | |
enterocyte | 6 studies | 28% ± 7% | |
interneuron | 6 studies | 59% ± 27% | |
retina horizontal cell | 6 studies | 27% ± 7% | |
retinal bipolar neuron | 5 studies | 28% ± 6% | |
retinal ganglion cell | 5 studies | 28% ± 10% | |
plasma cell | 5 studies | 20% ± 5% | |
amacrine cell | 5 studies | 34% ± 11% | |
cardiac muscle cell | 5 studies | 44% ± 11% | |
myofibroblast cell | 5 studies | 21% ± 3% | |
hepatocyte | 5 studies | 69% ± 25% | |
basal cell | 5 studies | 32% ± 14% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 24% ± 6% | |
granule cell | 4 studies | 42% ± 6% | |
abnormal cell | 4 studies | 36% ± 17% | |
platelet | 4 studies | 21% ± 6% | |
retinal cone cell | 4 studies | 28% ± 6% | |
Mueller cell | 4 studies | 20% ± 2% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 26% ± 2% | |
type I pneumocyte | 4 studies | 22% ± 4% | |
type II pneumocyte | 4 studies | 20% ± 5% | |
dendritic cell | 4 studies | 26% ± 9% | |
club cell | 4 studies | 23% ± 6% | |
pancreatic A cell | 3 studies | 32% ± 10% | |
type B pancreatic cell | 3 studies | 32% ± 8% | |
progenitor cell | 3 studies | 27% ± 3% | |
GABAergic interneuron | 3 studies | 55% ± 7% | |
retinal rod cell | 3 studies | 20% ± 3% | |
GABAergic amacrine cell | 3 studies | 32% ± 9% | |
ON-bipolar cell | 3 studies | 32% ± 8% | |
glycinergic amacrine cell | 3 studies | 29% ± 6% | |
rod bipolar cell | 3 studies | 39% ± 7% | |
ependymal cell | 3 studies | 37% ± 17% | |
enteroendocrine cell | 3 studies | 30% ± 8% | |
respiratory goblet cell | 3 studies | 23% ± 10% | |
transit amplifying cell | 3 studies | 27% ± 13% | |
connective tissue cell | 3 studies | 29% ± 17% | |
kidney loop of Henle epithelial cell | 3 studies | 24% ± 2% | |
renal alpha-intercalated cell | 3 studies | 21% ± 4% | |
renal principal cell | 3 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4734.58 | 226 / 226 | 100% | 40.27 | 406 / 406 |
ovary | 100% | 1800.86 | 180 / 180 | 100% | 17.43 | 430 / 430 |
prostate | 100% | 1320.27 | 245 / 245 | 100% | 20.12 | 502 / 502 |
breast | 100% | 1732.38 | 459 / 459 | 100% | 20.82 | 1115 / 1118 |
kidney | 100% | 2592.78 | 89 / 89 | 100% | 35.68 | 898 / 901 |
bladder | 100% | 1583.67 | 21 / 21 | 100% | 20.81 | 502 / 504 |
intestine | 100% | 1291.85 | 966 / 966 | 99% | 14.50 | 524 / 527 |
brain | 100% | 2152.18 | 2641 / 2642 | 99% | 23.36 | 701 / 705 |
lung | 100% | 1255.24 | 576 / 578 | 100% | 15.29 | 1151 / 1155 |
esophagus | 100% | 1376.34 | 1445 / 1445 | 98% | 14.02 | 180 / 183 |
adrenal gland | 100% | 1675.92 | 258 / 258 | 98% | 18.83 | 226 / 230 |
uterus | 99% | 843.57 | 169 / 170 | 98% | 16.05 | 452 / 459 |
stomach | 100% | 949.52 | 359 / 359 | 98% | 13.52 | 279 / 286 |
pancreas | 98% | 613.94 | 323 / 328 | 99% | 15.52 | 176 / 178 |
thymus | 100% | 2081.22 | 653 / 653 | 96% | 22.41 | 580 / 605 |
skin | 100% | 1199.03 | 1805 / 1809 | 79% | 7.20 | 374 / 472 |
adipose | 100% | 1571.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2166.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1064.75 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.26 | 1 / 1 |
heart | 98% | 1793.22 | 840 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 10.51 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 91% | 10.64 | 73 / 80 |
peripheral blood | 79% | 607.61 | 731 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.67 | 18 / 29 |
muscle | 51% | 336.59 | 413 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042758 | Biological process | long-chain fatty acid catabolic process |
GO_0012505 | Cellular component | endomembrane system |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0016787 | Molecular function | hydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AIG1 |
Protein name | Androgen-induced 1/Golgi SNAP receptor complex member 1 variant 2 fusion protein Androgen induced 1 Androgen-induced 1/Golgi SNAP receptor complex member 1 variant 1 fusion protein Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-) |
Synonyms | fusion CGI-103 GOSR1 |
Description | FUNCTION: Hydrolyzes bioactive fatty-acid esters of hydroxy-fatty acids (FAHFAs), but not other major classes of lipids . Show a preference for FAHFAs with branching distal from the carboxylate head group of the lipids . . |
Accessions | Q5T2H3 Q5T2H4 ENST00000367601.8 ENST00000646199.1 ENST00000447498.5 R9RVP2 ENST00000357847.9 [Q9NVV5-2] ENST00000367596.5 Q5T2H0 ENST00000275235.8 [Q9NVV5-1] ENST00000494282.6 [Q9NVV5-5] A0A2R8YCJ8 Q5THU2 Q9NVV5 ENST00000629020.2 [Q9NVV5-6] R9RV30 ENST00000458219.1 |